Targeted apoptosis-inducing effects of curcumin prodrug on bladder cancer cells

Chinese Pharmacological Bulletin

Volumn 22, Issue 10, 2006, Pages 1218-1222

  Lu, Peng ^a   Tong, Qiang Song ^b   Zeng, Fu Qing ^b   Jiang, Feng Chao ^c   Zheng, Li Duan ^b   Chen, Fang Min ^b   Zhang, Sheng Min ^d   Dong, Ji Hua ^b  

^a CHONGQING MEDICAL UNIVERSITY   (China)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^c HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^d The Key Laboratory of Plant Pathology of Hubei Province   (China)

Author keywords

Apoptosis; Bladder cancer; Curcumin; Prodrug

Indexed keywords

CURCUMIN; TRYPAN BLUE;

APOPTOSIS; ARTICLE; BLADDER CANCER; CELL VIABILITY; DRUG EFFECT; FLOW CYTOMETRY; HUMAN; HUMAN CELL; KIDNEY TUBULE EPITHELIUM;

EID: 33845534173     PISSN: 10011978     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. J Han R. Recent progress in the study of anticancer drugs originating from plants and traditional medicines in China[J]. Chin Med Sci J, 1994, 9(1);61-9.
2. Aggarwal B B, Kumar A, Bharti A C. Anticancer potential of curcumin; preclinical and clinical sludies[J]. Anticancer Res, 2003, 23(1A):363-98.
3. Kuttan R, Bhanumathy P, Nirmala K, et al. Potential anticancer activity of turmeric (Curcuma longa)[J]. Cancer Lett, 1985, 29 (2);197-202.
4. Lin J K, Pan M H, Lin-Shiau S Y. Recent studies on the biofunctions and biotransformations of curcumin[J]. Biofactors, 2000, 13 (1-4):153-8.
5. Lin J K, Lin-Shiau S Y. Mechanisms of cancer chemoprevention by curcumin[J]. Proc Natl Sci Counc Repub China R, 2001, 25 (2):59-66.
6. Calabro F, Sternberg C N. New drugs and new approaches for the treatment of metastatic urothelial cancer[J]. World J Urol, 2002, 20(3):158-66.
7. Lu P, Tong Q S, Jiang F C. Preparation of curcumin prodrugs and their anti-tumor activities in vitro[J]. Chin Pharmacol Bull, 2006, 22(3):321-4.
8. Zheng L, Tong Q, Wu C. Growth-inhibitory effects of curcumin on ovary cancer cells and its mechanisms[J]. J Huazhong Univ Sci Technolog Med Sci, 2004, 24(1):55-8.
9. Zheng L, Tong Q S, Wu C H. Inhibitory effects of curcumin on apoptosis of human ovary cancer cell line A2780 and its molecular mechanisim[J]. Ai Zheng, 2002, 21(12):1296-300.
10. Wu L X, Xu J H, Wu G H, Chen Y Z. Inhibition of curcumin on proliferation of K562 cells and down-regulation of P210 (bcl/abl)-initiated ras signal pathway[J]. Chin Pharmacol Bull, 2003, 19 (1):33-7.
11. Denny W A. Prodrug strategies in cancer therapy[J]. Eur J Med Chem, 2001, 36(7-8):577-95.